Cocokara Fine Incorporated operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cocokara Fine Incorporated with three other
companies in this sector in Japan:
Sugi Holdings Company Limited
sales of 430.80 billion Japanese Yen [US$3.88 billion]
of which 100%
was Drug Compounding Business),
Cosmos Pharmaceutical Corp
(502.73 billion Japanese Yen [US$4.52 billion]
(266.42 billion Japanese Yen [US$2.40 billion]
of which 46%
was General food).
During the year ended March of 2017, sales at
Cocokara Fine Incorporated were ¥377.20 billion (US$3.39 billion).
a very small
increase of 1.1%
versus 2016, when the company's sales were ¥373.28 billion.
Sales of Care saw an increase
that was more than double the company's growth rate: sales were up
7.4% in 2017, from
¥2.24 billion to ¥2.41 billion.